scispace - formally typeset
N

Naoki Horikawa

Researcher at Kyoto University

Publications -  19
Citations -  1499

Naoki Horikawa is an academic researcher from Kyoto University. The author has contributed to research in topics: Ovarian cancer & Medicine. The author has an hindex of 7, co-authored 15 publications receiving 1041 citations.

Papers
More filters
Journal ArticleDOI

IFN-γ From Lymphocytes Induces PD-L1 Expression and Promotes Progression of Ovarian Cancer

TL;DR: The lymphocyte infiltration and the IFN-γ status may be the key to effective anti- PD-1 or anti-PD-L1 therapy in ovarian cancer.
Journal ArticleDOI

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

TL;DR: It is found that chemotherapy induces local immune suppression in ovarian cancer through NF-κB-mediated PD-L1 upregulation and a combination of chemotherapy and immunotherapy targeting the PD- L1/PD-1 signaling axis may improve the antitumor response and offers a promising new treatment modality against ovarian cancer.
Journal ArticleDOI

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.

TL;DR: It is shown that, in the mesenchymal subtype of ovarian cancer, Snail expression promotes tumorigenesis by inducing immune evasion through CXCR2-ligands-mediated recruitment of myeloid-derived suppressor cells.
Journal ArticleDOI

Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells

TL;DR: VEGF expression in ovarian cancer induced MDSCs, inhibited local immunity, and contributed to poor prognosis, according to Clin Cancer Res; 23(2); 587–99.
Journal ArticleDOI

VISTA expressed in tumour cells regulates T cell function

TL;DR: This is the first demonstration that VISTA is highly expressed in human ovarian and endometrial cancer cells, and that anti-VISTA antibody treatment significantly prolongs the survival of mice bearing tumour-bearing mice.